Cozad Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.55M | Sell |
21,181
-67
| -0.3% | -$7.74K | 0.2% | 114 |
|
|
2025
Q4 | $2.24M | Buy |
21,248
+104
| +0.5% | +$9.76K | 0.17% | 131 |
|
|
2025
Q3 | $1.77M | Sell |
21,144
-523
| -2% | -$43.1K | 0.14% | 155 |
|
|
2025
Q2 | $1.72M | Sell |
21,667
-531
| -2% | -$42.2K | 0.15% | 144 |
|
|
2025
Q1 | $1.99M | Sell |
22,198
-18,857
| -46% | -$1.76M | 0.2% | 132 |
|
|
2024
Q4 | $4.08M | Sell |
41,055
-476
| -1% | -$49.1K | 0.38% | 72 |
|
|
2024
Q3 | $4.72M | Sell |
41,531
-1,366
| -3% | -$162K | 0.45% | 58 |
|
|
2024
Q2 | $5.31M | Buy |
42,897
+687
| +2% | +$88.5K | 0.53% | 48 |
|
|
2024
Q1 | $5.57M | Sell |
42,210
-1,488
| -3% | -$183K | 0.58% | 47 |
|
|
2023
Q4 | $4.76M | Sell |
43,698
-1,866
| -4% | -$194K | 0.55% | 47 |
|
|
2023
Q3 | $4.69M | Sell |
45,564
-534
| -1% | -$57.6K | 0.61% | 43 |
|
|
2023
Q2 | $5.32M | Sell |
46,098
-187
| -0.4% | -$21.2K | 0.66% | 37 |
|
|
2023
Q1 | $4.92M | Sell |
46,285
-1,179
| -2% | -$127K | 0.65% | 38 |
|
|
2022
Q4 | $5.27M | Buy |
47,464
+3,168
| +7% | +$324K | 0.74% | 36 |
|
|
2022
Q3 | $3.81M | Sell |
44,296
-1,321
| -3% | -$118K | 0.62% | 40 |
|
|
2022
Q2 | $4.16M | Buy |
45,617
+1,038
| +2% | +$92K | 0.65% | 40 |
|
|
2022
Q1 | $3.66M | Buy |
44,579
+3,782
| +9% | +$298K | 0.51% | 53 |
|
|
2021
Q4 | $3.13M | Sell |
40,797
-177
| -0.4% | -$14.1K | 0.44% | 60 |
|
|
2021
Q3 | $3.08M | Sell |
40,974
-1,133
| -3% | -$86.2K | 0.48% | 55 |
|
|
2021
Q2 | $3.27M | Sell |
42,107
-3,415
| -8% | -$254K | 0.51% | 53 |
|
|
2021
Q1 | $3.35M | Buy |
45,522
+2,098
| +5% | +$155K | 0.54% | 46 |
|
|
2020
Q4 | $3.39M | Sell |
43,424
-3,216
| -7% | -$246K | 0.61% | 45 |
|
|
2020
Q3 | $3.69M | Sell |
46,640
-386
| -0.8% | -$30.2K | 0.7% | 37 |
|
|
2020
Q2 | $3.47M | Buy |
47,026
+759
| +2% | +$57.1K | 0.71% | 36 |
|
|
2020
Q1 | $3.4M | Sell |
46,267
-6,878
| -13% | -$541K | 1.17% | 22 |
|
|
2019
Q4 | $4.61M | Sell |
53,145
-773
| -1% | -$63.5K | 1.23% | 20 |
|
|
2019
Q3 | $4.33M | Buy |
53,918
+810
| +2% | +$64.9K | 1.25% | 17 |
|
|
2019
Q2 | $4.25M | Sell |
53,108
-459
| -0.9% | -$35.1K | 1.23% | 20 |
|
|
2019
Q1 | $4.25M | Sell |
53,567
-197
| -0.4% | -$14.7K | 1.28% | 17 |
|
|
2018
Q4 | $3.92M | Buy |
53,764
+2,880
| +6% | +$203K | 1.35% | 17 |
|
|
2018
Q3 | $3.44M | Sell |
50,884
-60
| -0.1% | -$3.82K | 1.01% | 25 |
|
|
2018
Q2 | $2.95M | Buy |
+50,944
| New | +$2.87M | 0.92% | 28 |
|
Other funds holding MRK
VCM
VPM
Cozad Asset Management's MRK Position: Q1 2026 in Review
Cozad Asset Management reduced its Merck (MRK) stake by 0.32% in Q1 2026, selling an estimated $7.74K and leaving 21,181 shares worth $2.55M. The position accounts for 0.2% of the portfolio, ranked #114.
Cozad Asset Management first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $5.57M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Cozad Asset Management held 21,181 shares of Merck worth $2.55M as of Q1 2026.
- Cozad Asset Management sold 67 Merck shares in Q1 2026, an estimated $7.74K.
- Merck made up 0.2% of Cozad Asset Management's portfolio in Q1 2026, its #114 holding.
- Cozad Asset Management first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
- Cozad Asset Management's Merck position peaked at $5.57M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.